𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis, radiofluorination and first evaluation of (±)-[18F]MDL 100907 as serotonin 5-HT2A receptor antagonist for PET

✍ Scribed by Ute Mühlhausen; Johannes Ermert; Matthias M. Herth; Heinz H. Coenen


Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
231 KB
Volume
52
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

✦ Synopsis


In some psychiatric disorders 5-HT 2A receptors play an important role. In order to investigate those in vivo there is an increasing interest in obtaining a metabolically stable, subtype selective and high affinity radioligand for receptor binding studies using positron emission tomography (PET). Combining the excellent in vivo properties of [ 11 C]MDL 100907 for PET imaging of 5-HT 2A receptors and the more suitable half-life of fluorine-18, MDL 100907 was radiofluorinated in four steps using 1-(2-bromoethyl)-4-[ 18 F]fluorobenzene as a secondary labelling precursor. The complex reaction required an overall reaction time of 140 min and (7)-[ 18 F]MDL 100907 was obtained with a specific activity of at least 30 GBq/mmol (EOS) and an overall radiochemical yield of 1-2%. In order to verify its binding to 5-HT 2A receptors, in vitro rat brain autoradiography was conducted showing the typical distribution of 5-HT 2A receptors and a very low non-specific binding of about 6% in frontal cortex, using ketanserin or spiperone for blocking. Thus, [ 18 F]MDL 100907 appears to be a promising new 5-HT 2A PET ligand.


📜 SIMILAR VOLUMES


Synthesis, labelling and first evaluatio
✍ Ute Mühlhausen; Johannes Ermert; Heinz H. Coenen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 226 KB

## Abstract In psychiatric disorders such as anxiety, depression and schizophrenia, 5‐HT~2A~ receptors play an important role. In order to investigate them __in vivo__ there is an increasing interest in selective and high‐affinity radioligands for receptor binding studies using positron emission to

Synthesis of novel WAY 100635 derivative
✍ Matthias M. Herth; Vasko Kramer; Frank Rösch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 265 KB

## Abstract 5‐HT~1A~ receptors are involved in a variety of psychiatric disorders and __in vivo__ molecular imaging of the 5‐HT~1A~ status represents an important approach to analyze and treat these disorders. We report herein the synthesis of three new fluoroethylated 5‐HT~1A~ ligands (AH1.MZ, AH2

Synthesis and preliminary in vivo evalua
✍ M. Vandecapelle; F. Dumont; F. De Vos; K. Strijckmans; D. Leysen; K. Audenaert; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB 👁 1 views

## Abstract 4‐Fluoro‐__N__‐{2‐[4‐(6‐trifluoromethylpyridin‐2‐yl)piperazin‐1‐yl]ethyl}benzamide is a full 5‐HT~1A~ agonist with high affinity (__pK__~__i__~=9.3), selectivity and a __c__ log __P__ of 3.045. The corresponding PET radioligand 4‐[^18^F]fluoro‐__N__‐{2‐[4‐(6‐trifluoromethylpyridin‐2‐yl)

Synthesis and in vivo evaluation in mice
✍ P. Blanckaert; I. Burvenich; F. Devos; G. Slegers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 119 KB 👁 1 views

## Abstract This work reports the synthesis, radiolabelling and __in vivo__ evaluation in NMRI mice of [^123^I]‐(4‐fluorophenyl)[1‐(3‐iodophenethyl)piperidin‐4‐yl]methanone ([^123^I]‐3‐I‐CO) as a potential SPECT tracer for the 5‐HT~2A~ receptor. The tributylstannylprecursor was synthesized with a 1